Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(50%)
Results Posted
100%(1 trials)

Phase Distribution

Ph phase_4
1
25%
Ph not_applicable
1
25%
Ph phase_3
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
2(50.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(1)
Other(1)

Detailed Status

unknown1
Recruiting1
Active, not recruiting1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 32 (50.0%)
Phase 41 (25.0%)
N/A1 (25.0%)

Trials by Status

unknown125%
recruiting125%
active_not_recruiting125%
completed125%

Recent Activity

2 active trials
Showing 4 of 4
active_not_recruitingnot_applicable

1-month vs 12-month DAPT for ACS Patients Who Underwent PCI Stratified by IVUS: IVUS-ACS and ULTIMATE-DAPT Trials

NCT03971500
recruitingphase_3

PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years

NCT05387954
unknownphase_4

Efficacy and Safety of Adjunctive Cilostazol in Acute Myocardial Infarction Patients

NCT01261832
completedphase_3

EPIC Nitinol Stent System in the Treatment of Atherosclerotic Lesions in Iliac Arteries

NCT00896337

Clinical Trials (4)

Showing 4 of 4 trials
NCT03971500Not Applicable

1-month vs 12-month DAPT for ACS Patients Who Underwent PCI Stratified by IVUS: IVUS-ACS and ULTIMATE-DAPT Trials

Active Not Recruiting
NCT05387954Phase 3

PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years

Recruiting
NCT01261832Phase 4

Efficacy and Safety of Adjunctive Cilostazol in Acute Myocardial Infarction Patients

Unknown
NCT00896337Phase 3

EPIC Nitinol Stent System in the Treatment of Atherosclerotic Lesions in Iliac Arteries

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4